Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 85

1.

High-content, image-based screening for drug targets in yeast.

Ohnuki S, Oka S, Nogami S, Ohya Y.

PLoS One. 2010 Apr 14;5(4):e10177. doi: 10.1371/journal.pone.0010177.

2.

Yeast as a tool to uncover the cellular targets of drugs.

Sturgeon CM, Kemmer D, Anderson HJ, Roberge M.

Biotechnol J. 2006 Mar;1(3):289-98. Review.

PMID:
16897709
3.

Yeast and drug discovery.

Hughes TR.

Funct Integr Genomics. 2002 Sep;2(4-5):199-211. Review.

PMID:
12192593
4.

Yeast as a drug discovery platform in Huntington's and Parkinson's diseases.

Outeiro TF, Giorgini F.

Biotechnol J. 2006 Mar;1(3):258-69. Review.

PMID:
16897706
6.

Drug discovery through functional screening in the Drosophila heart.

Akasaka T, Ocorr K.

Methods Mol Biol. 2009;577:235-49. doi: 10.1007/978-1-60761-232-2_18.

PMID:
19718521
7.

Chemical genetics: budding yeast as a platform for drug discovery and mapping of genetic pathways.

Enserink JM.

Molecules. 2012 Aug 2;17(8):9258-73. doi: 10.3390/molecules17089258. Review.

8.

Synthetic genetic array (SGA) analysis in Saccharomyces cerevisiae and Schizosaccharomyces pombe.

Baryshnikova A, Costanzo M, Dixon S, Vizeacoumar FJ, Myers CL, Andrews B, Boone C.

Methods Enzymol. 2010;470:145-79. doi: 10.1016/S0076-6879(10)70007-0.

PMID:
20946810
9.

Yeast cells as tools for target-oriented screening.

Munder T, Hinnen A.

Appl Microbiol Biotechnol. 1999 Sep;52(3):311-20. Review.

PMID:
10531642
10.

Identification of response-modulated genetic interactions by sensitivity-based epistatic analysis.

Batenchuk C, Tepliakova L, Kaern M.

BMC Genomics. 2010 Sep 10;11:493. doi: 10.1186/1471-2164-11-493.

11.

Yeast genomics and drug target identification.

Bharucha N, Kumar A.

Comb Chem High Throughput Screen. 2007 Sep;10(8):618-34. Review.

PMID:
18045076
12.

Genetic Screens for Determination of Mechanism of Action.

Gay-Andrieu F, Alex D, Calderone R.

Methods Mol Biol. 2016;1356:165-72. doi: 10.1007/978-1-4939-3052-4_12.

PMID:
26519072
14.

The utility of yeast as a tool for cell-based, target-directed high-throughput screening.

Norcliffe JL, Alvarez-Ruiz E, Martin-Plaza JJ, Steel PG, Denny PW.

Parasitology. 2014 Jan;141(1):8-16. doi: 10.1017/S0031182013000425. Review.

PMID:
23611102
15.

Identification of drug targets by chemogenomic and metabolomic profiling in yeast.

Wu M, Zheng M, Zhang W, Suresh S, Schlecht U, Fitch WL, Aronova S, Baumann S, Davis R, St Onge R, Dill DL, Peltz G.

Pharmacogenet Genomics. 2012 Dec;22(12):877-86. doi: 10.1097/FPC.0b013e32835aa888.

PMID:
23076370
16.

Yeast models of human mitochondrial diseases: from molecular mechanisms to drug screening.

Schwimmer C, Rak M, Lefebvre-Legendre L, Duvezin-Caubet S, Plane G, di Rago JP.

Biotechnol J. 2006 Mar;1(3):270-81. Review.

PMID:
16897707
17.

Combining functional genomics and chemical biology to identify targets of bioactive compounds.

Ho CH, Piotrowski J, Dixon SJ, Baryshnikova A, Costanzo M, Boone C.

Curr Opin Chem Biol. 2011 Feb;15(1):66-78. doi: 10.1016/j.cbpa.2010.10.023. Review.

PMID:
21093351
18.
19.
20.

Differentiation and visualization of diverse cellular phenotypic responses in primary high-content screening.

Kümmel A, Selzer P, Siebert D, Schmidt I, Reinhardt J, Götte M, Ibig-Rehm Y, Parker CN, Gabriel D.

J Biomol Screen. 2012 Jul;17(6):843-9. doi: 10.1177/1087057112439324.

PMID:
22396475

Supplemental Content

Support Center